MEGGLE Excipients & Technology

MEGGLE – Experts in Excipients

MEGGLE Excipients & Technology produces pharmaceutical excipients for direct compression, granulation, capsules, sachets, powder blends and dry powder inhalation. With its broad product portfolio, intelligent innovations and exceptional product quality, MEGGLE took a leading role in the global business of pharmaceutical excipients. With production facilities in Wasserburg (Germany) and Le Sueur, Minnesota (USA), where the requirements of the North American market are served, MEGGLE is prepared to meet customer expectations worldwide.

Request a sample


product overview meggle

Milled lactose – for optimum granulation

GranuLac® and SorboLac®, milled lactose, have good compaction properties due to its small particle size. It is best granulated, wet or dry, before tablet production. It is the most frequently used excipient for granulation.


  • Wet granulation
  • Dry granulation
  • Premixes
  • Triturations
  • Fermentation
  • Flavor enhancement

Product features:

  • Good compactability
  • Good blending properties
  • Narrow particle size distribution
  • High storage stability
  • High batch-to-batch consistency


  • GranuLac® 70
  • GranuLac® 140
  • GranuLac® 200
  • GranuLac® 230
  • SorboLac® 400

Sieved lactose – with superior blending properties.

Lactose is sieve-fractionated into various grades with a narrow particle size distribution and exhibits good flow. Sieved lactose consists of mono-crystals and agglomerates. Our product variety allows your application to be easily optimized. Due to good blending properties and excellent flowability, our products are especially suitable for powder blends, and capsule and sachet filling.


  • Capsule filling
  • Sachet filling
  • Powder blends
  • Triturations

Product features:

  • Excellent flowability
  • Narrow particle size distribution
  • Good blending properties
  • High storage stability
  • High batch-to-batch consistency


  • PrismaLac® 40
  • CapsuLac® 60
  • SacheLac® 80
  • SpheroLac® 100


Request a sample

Direct compression (DC) – maximum profitability.

Direct compression is the least complex and most cost-effective alternative to traditional granulation. Because they are convenient and easy to administer, tablets are the most popular pharmaceutical dosage form. They can be produced inexpensively in large volumes. Moreover, dosing accuracy is consistent. Given the efficiencies, direct compression is becoming the preferred process for tablet manufacture by pharmaceutical companies globally. Decreased energy, labor, and capital costs as well as the increase in overall product stability are a few of the many benefits.

Few traditional excipients provide the functional characteristics, specifically powder flow and compactability, required for robust direct compression tablet manufacture. As a result, modifying traditional excipients may be necessary. This may be accomplished through spray-drying, agglomeration, roller-drying, or co-processing lactose to enhance the functional characteristics desired for directly compressed pharmaceutical dosage forms.


meggle tablettose dryer
Agglomaration equipment
  • Tablettose® 70
  • Tablettose® 80
  • Tablettose® 100
  • FlowLac® 90
  • FlowLac® 100
  • DuraLac® H



Co-processed excipients:

MEGGLE is a pioneer in co-processing technologies that allow simple, robust formulation development and manufacture. Through co-processing, MEGGLE developed highly functional excipients possessing unique qualities for directly compressible immediate and sustained release pharmaceutical solid dosage forms.


  • Cellactose® 80
  • MicroceLac® 100
  • StarLac®
  • RetaLac®
  • CombiLac®


CELLACTOSE MicroceLac StarLac Combilac RetaLac

inhaLac header

Lactose for inhalation applications – versatile, in line with your needs.

meggle inhalation clean room
Sieving Inhalation

MEGGLE’s InhaLac® – high quality crystalline lactose-based excipients are specifically designed to support dry powder inhalation formulations. These sieved, milled, micronized and customized lactose monohydrate grades are available in a wide range of particle sizes and are particularly suitable for use in pulmonary and nasal drug delivery systems.

InhaLac® is tightly controlled sieved or milled lactose specifically designed and especially suited for dry powder inhalation drug delivery. InhaLac® products are available in standard forms or as customized solutions to suit your exacting needs. InhaLac® fulfills the need for excellent flowability, defined particle surface, and chemical and physical stability in dry powder inhalation drug delivery.

InhaLac® is perfect for these applications due to the extremely narrow particle size distribution. This specialized excipient is practically free of unstable, amorphous lactose.


  • InhaLac® 70
  • InhaLac® 120
  • InhaLac® 140
  • InhaLac® 150
  • InhaLac® 160
  • InhaLac® 230
  • InhaLac® 251
  • InhaLac® 400
  • InhaLac® 500

Header experts in excipients meggle



Milled and Sieved Lactose











MEGGLE stands for expertise: Wherever you are – we’re there for you

MEGGLE Excipients & Technologies serves the pharmaceutical and biotechnology markets with a global network of offices and authorized agents. As an innovator in co-processed technology, MEGGLE also provides contract manufacturing services to several other global excipient companies. Our broad portfolio of products, multiple manufacturing locations, technical centers in major markets, and innovative technologies, make MEGGLE the preferred supplier and valued partner by large and small pharmaceutical product manufacturers.

Modern spray tower with an external fluidized bed drier
Modern spray tower with an external fluidized bed drier.

Contract manufacturing

MEGGLE is contract manufacturing various products for their customers also. With a broad spectrum of effort and state-of-the- art production equipment, MEGGLE is able to realize customer requirements quickly, reliably, and with the highest technical level.

Quality Standards: ISO 9001, ISO 14001, ISO 45001, ISO 50001, FAMI-QS, HACCP, IPEC GMP, Process-and Cleaning Validation for pharmaceutical products possible

Production Equipment:

  • 8 Spray-Dryer
  • 5 Fluid bed dryer
  • 10 Evaporator


  • Spray-drying
  • Agglomeration/drying
  • Evaporation

MEGGLE quality standards are simple: Do everything better

MEGGLE Group Wasserburg was granted an EXCiPACT™ certificate. Auditors from the certifying body SGS (Société Générale de Surveillance, Hamburg, Germany) confirmed that the MEGGLE Business Group Excipients & Technology complies with the quality standards of Good Manufacturing & Good Distribution Practices (GMP & GDP) for its pharmaceutical excipients.

About MEGGLE: How we got where we are today

Founded in 1887 as a small dairy in Wasserburg near Munich, Germany, MEGGLE is a privately held, third generation, family owned business. With an emphasis on quality and innovation, the company is a global leader and premiere manufacturer of dairy products. The company is represented by more than 2,500 employees worldwide.


MEGGLE Group Wasserburg
BG Excipients & Technology
Megglestrasse 6 –12
83512 Wasserburg


Phone +49 8071 73 476
Fax +49 8071 73 320
[email protected]

aerial view of meggle
Meggle Headquarter